Clinical Research
Avistone Biotechnology Presents Promising Clinical Results of Dual c-MET and EGFR Inhibitors for NSCLC at WCLC 2024
Beijing Avistone Biotechnology Co., Ltd. (also referred to as Avistone Biotechnology or Avistone), an innovative biotechnology company focused on precision...
September 11, 2024 | News
MGI Introduces CycloneSEQ-WT02 and CycloneSEQ-WY01, Advancing High-Throughput Nanopore Sequencing
MGI Tech Co., Ltd. ("MGI"), a company committed to building core tools and technologies that drive innovation in life science, today announced the global r...
September 10, 2024 | Product Spotlight
Neurophet Expands Global Reach with AI Brain Imaging Partnership and Research Recognition
Neurophet accelerates global expansion for research and partnership in AI-driven brain image analysis Neurophet, an artificial intelligence (AI) solution ...
September 10, 2024 | News
Janssen-Cilag International Announces Superior Long-Term Outcomes of Amivantamab Plus Lazertinib from MARIPOSA Study
Janssen-Cilag International NV, a Johnson & Johnson company, announced new longer follow-up data from the landmark Phase 3 MARIPOSA study. These ...
September 09, 2024 | News
Daiichi Sankyo and AstraZeneca’s Datopotamab Deruxtecan Shows Superior Progression-Free Survival in Biomarker-Positive NSCLC Patients
Daiichi Sankyo and AstraZeneca’s datopotamab deruxtecan demonstrated meaningfully greater magnitude of progression-free survival benefit in p...
September 09, 2024 | News
Merck Launches Global Phase III Trial of Oral Cladribine for Generalized Myasthenia Gravis Treatment
MyClad is a global Phase III study evaluating the efficacy and safety of cladribine capsules for the treatment of generalized Myasthenia Gravis (gMG) Cl...
September 06, 2024 | News
Crucial Data Solutions Unveils AI-Powered Module to Revolutionize Clinical Trial Data Analysis
Crucial Data Solutions, a leading provider of data collection and trial management software to advance clinical research, has announced the launch of...
September 06, 2024 | News
Vetter’s Rankweil Site Expands as Project Orders Surge, Completing First 100 Aseptic Batches
An increase in project orders drives further site growth The first 100 aseptic batches at Vetter’s Rankweil site predict a successful future The ...
September 06, 2024 | News
Regenity Biosciences Secures NMPA Approval for Matrixflex™ Collagen Dental Membrane in China
Regenity Biosciences, a global leader in regenerative medicine and Linden Capital Partners portfolio company, today announced it has received regulatory ap...
September 05, 2024 | News
Acepodia Partners with Pfizer Ignibiolote to Advance Cell Therapies for Autoimmune Diseases and Oncology
Through Pfizer Ignite, Acepodia will gain access to Pfizer's resources, scale and expertise as the company broadens the application of its platform beyon...
September 04, 2024 | News
Merck Initiates Phase III MyClad Trial Dosing First Patient in Study of Oral Cladribine for Generalized Myasthenia Gravis
Merck, a leading science and technology company, announced the first patient has been dosed in the Phase III MyClad trial (NCT06463587) evaluating the effi...
August 30, 2024 | News
Yunovia Gains MFDS Clearance for Phase 1 MAD Study of Oral GLP-1 Agonist for Diabetes and Obesity
Yunovia, a drug R&D subsidiary of Ildong Pharmaceutical Group, announced on the 26th that the Ministry of Food and Drug Safety (MFDS) of Korea has clea...
August 28, 2024 | News
Shilpa Medicare Completes Phase 1 Trial for sRbumin®, India’s First Recombinant Human Albumin
Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED) proudly announces the successful completion of its Phase 1 clinical trial for its flagship prod...
August 28, 2024 | News
HKBU Research Identifies Phosphocholine as a Potential Therapy for PM2.5-Related Lung Damage
A research team led by Hong Kong Baptist University (HKBU) has discovered that phosphocholine, an important component in the body's metabolism, c...
August 28, 2024 | News
Most Read
- Bridging the Vision Gap: Roche’s Ahmed Elhusseiny on Eye Health Priorities in Asia Pacific
- How Merck’s India-Based Navi Mumbai Centre is Reimagining Formulation Science for the Global Generics Market
- Advancing Cell & Gene Therapy in APJ: How Thermo Fisher Enables Breakthrough Innovation
- AstraZeneca’s Vision for Chronic Kidney Disease: Sylvia Varela on Transforming CKD Care in Asia
- ACG Leads the Charge in Vegan Capsules: Innovation, Certification, and the Future of Sustainable Pharma
- ORA’s Hybrid Model Reshapes Obesity Care: Dr. Ben Ng on Bridging Telehealth and In-Person Treatment
- Heather Hargett on How Merck’s HUB Organoids Acquisition is Reshaping 3D Cell Culture and Drug Development
- Health2Sync's Vision for Diabetes Care: Transforming Outcomes Through Technology and Partnerships
Bio Jobs
- Ravindra Rao Joins GOBI Technologies as Director of Life Sciences – APAC
- Amgen Announces $900 Million Expansion of Ohio Biomanufacturing Facility, Boosting Investment to Over $1.4 Billion
- Thermo Fisher Scientific Appoints Former CVS Health CEO Karen S. Lynch to Board of Directors
- Merck KGaA Reshapes Leadership for the Future with Key Executive Moves
- Aarian Health Appoints Thomas Keller as Business Director to Drive Innovation and Growth
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
News
Editor Picks
